A California-based biotech company is turning heads on Wednesday morning after it was announced that the company received FDA approval for the supplemental new drug application...

To read the full story on AllPennyStocks.com, click here.

Heron Therapeautics (NASDAQ:HRTX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Heron Therapeautics.
Heron Therapeautics (NASDAQ:HRTX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Heron Therapeautics.